Cargando…
Screening Novel Molecular Targets of Metformin in Breast Cancer by Proteomic Approach
Metformin is a commonly prescribed antihyperglycemic drug, and has been investigated in vivo and in vitro for its effect to improve the comorbidity of diabetes and various types of cancers. Several studies investigated the therapeutic mechanisms of metformin on cancer cells, but the exact mechanism...
Autores principales: | Al-Zaidan, Lobna, El Ruz, Rasha Abu, Malki, Ahmed M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650619/ https://www.ncbi.nlm.nih.gov/pubmed/29085821 http://dx.doi.org/10.3389/fpubh.2017.00277 |
Ejemplares similares
-
Metformin and Chemoprevention: Potential for Heart-Healthy Targeting of Biologically Aggressive Breast Cancer
por: Jones, Veronica C., et al.
Publicado: (2020) -
Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements
por: Malki, Ahmed, et al.
Publicado: (2020) -
Epstein–Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis
por: El-Sharkawy, Ahmed, et al.
Publicado: (2018) -
Public Awareness and Knowledge of Pap Smear as a Screening Test for Cervical Cancer among Saudi Population in Riyadh City
por: Al Khudairi, Hassan, et al.
Publicado: (2017) -
Understanding Reciprocity Among University Students in Low-Resource Settings: Validation and Measurement Using a Mixed-Methods Approach
por: AbuAlSamen, Mahmoud M., et al.
Publicado: (2022)